Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,471,280 | 4,066,790 | 5,768,420 | 5,299,820 | 4,426,980 |
| Depreciation Amortization | 1,234,670 | 1,204,900 | 316,900 | 244,230 | 245,530 |
| Other Working Capital | 152,120 | -376,700 | -87,110 | -303,890 | -85,580 |
| Other Operating Activity | -1,759,490 | -1,565,680 | -3,073,260 | -3,466,610 | -1,393,990 |
| Operating Cash Flow | $4,098,580 | $3,329,310 | $2,924,950 | $1,773,550 | $3,192,940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -926,950 | -396,990 | -303,900 | -194,400 | -266,610 |
| Net Acquisitions | -74,000 | -8,083,280 | -17,560 | -40,030 | 92,060 |
| Other Investing Activity | -262,710 | 651,130 | 1,338,950 | 1,220,800 | 230,660 |
| Investing Cash Flow | $-1,263,660 | $-7,829,140 | $1,017,490 | $986,370 | $56,110 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1,543,590 | -1,453,530 | -1,291,670 | -836,920 | -731,010 |
| Other Financing Activity | -48,300 | -2,891,770 | -1,329,150 | -1,840,550 | -32,150 |
| Financing Cash Flow | $-1,591,890 | $-4,345,300 | $-2,620,820 | $-2,677,470 | $-763,160 |
| Exchange Rate Effect | -227,980 | 119,030 | -1,666,160 | 99,390 | 607,350 |
| Beginning Cash Position | 8,151,410 | 16,461,630 | 16,476,940 | 13,781,650 | 10,806,180 |
| End Cash Position | 9,166,450 | 7,735,530 | 16,132,400 | 13,963,500 | 13,899,440 |
| Net Cash Flow | $1,015,030 | $-8,726,100 | $-344,540 | $181,850 | $3,093,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,098,580 | 3,329,310 | 2,924,950 | 1,773,550 | 3,192,940 |
| Free Cash Flow | 4,098,580 | 3,329,310 | 2,924,950 | 1,773,550 | 3,192,940 |